Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × dolastatin 10 × Clear all

NCT00003677 2018-10-25

Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms